Application of Nanoparticles and Nano Technology for Treating Various Diseases Like Tumors and Carcinoma in Animals
DOI:
https://doi.org/10.48047/HM.10.2.2024.2106-2127Keywords:
Nanoparticles, Veterinary Oncology, Nanotechnology, Targeted Drug Delivery, Diagnostic Imaging, Theranostics, NanovaccinesAbstract
The application of nanoparticles and nanotechnology in treating diseases such as tumors and carcinoma in animals is revolutionizing veterinary care. This review synthesizes existing information regarding the utilization of nanoparticles in veterinary oncology, assesses their therapeutic and diagnostic uses, and investigates upcoming technologies such as nano vaccines and theranostics. This review critically analyzes recent advancements to identify key trends and innovations in nanoparticle formulations, targeted delivery systems, and multimodal imaging techniques while addressing notable gaps in the literature, such as the inconsistent efficacy of nanoparticle therapies across species and their toxicological and environmental implications. This review emphasizes the many categories of nanoparticles, including liposomes, dendrimers, and polymeric nanoparticles, and their distinct roles in veterinary cancer. It analyzes the difficulties presented by tumor biology, diversity, species-specific pharmacokinetics, and regulatory obstacles that hinder the broad implementation of nanoparticle-based therapeutics. This review examines the amalgamation of diagnostics and treatments via theranostic methodologies and the advancement of nano vaccines to boster immune responses against animal cancer. This underscores the necessity for species-specific formulations, environmentally sustainable processes, and thorough safety evaluations to guarantee the responsible implementation of nanotechnology in veterinary medicine. This review offers significant insights for forthcoming research, clinical implementation, and policy formulation by examining these essential elements. This highlights the capacity of nanoparticles to transform veterinary oncology while promoting interdisciplinary cooperation to address current challenges. This synthesis seeks to enhance discipline, connect veterinary and human oncology, and foster innovation in cancer therapy.
Downloads
References
Alkilany, A. M., & Murphy, C. J. (2010). Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? Journal of nanoparticle research, 12, 2313-2333.
Allahou, L. W., Madani, S. Y., & Seifalian, A. (2021). Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. International journal of biomaterials, 2021(1), 3041969.
Anselmo, A. C., & Mitragotri, S. (2019). Nanoparticles in the clinic: An update. Bioengineering & translational medicine, 4(3), e10143.
Aragao-Santiago, L., Bohr, A., Delaval, M., C Dalla-Bona, A., Gessler, T., Seeger, W., & Beck-Broichsitter, M. (2016). Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome. Current pharmaceutical design, 22(9), 1147-1160.
Arms, L., Smith, D. W., Flynn, J., Palmer, W., Martin, A., Woldu, A., & Hua, S. (2018). Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles. Frontiers in pharmacology, 9, 802.
Axiak-Bechtel, S. M., Upendran, A., Lattimer, J. C., Kelsey, J., Cutler, C. S., Selting, K. A., Bryan, J. N., Henry, C. J., Boote, E., & Tate, D. J. (2014). Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer. International journal of nanomedicine, 5001-5011.
Bai, D.-P., Lin, X.-Y., Huang, Y.-F., & Zhang, X.-F. (2018). Theranostics aspects of various nanoparticles in veterinary medicine. International Journal of Molecular Sciences, 19(11), 3299.
Bai, X., Wang, Y., Song, Z., Feng, Y., Chen, Y., Zhang, D., & Feng, L. (2020). The basic properties of gold nanoparticles and their applications in tumor diagnosis and treatment. International Journal of Molecular Sciences, 21(7), 2480.
Bardania, H., Tarvirdipour, S., & Dorkoosh, F. (2017). Liposome-targeted delivery for highly potent drugs. Artificial cells, nanomedicine, and biotechnology, 45(8), 1478-1489.
Bouché, M., Hsu, J. C., Dong, Y. C., Kim, J., Taing, K., & Cormode, D. P. (2019). Recent advances in molecular imaging with gold nanoparticles. Bioconjugate chemistry, 31(2), 303-314.
Brundo, M. V., & Salvaggio, A. (2018). Zebrafish or Danio rerio: a new model in nanotoxicology study. Recent advances in zebrafish researches, 10, 121-133.
Buhr, C. R., Wiesmann, N., Tanner, R. C., Brieger, J., & Eckrich, J. (2020). The chorioallantoic membrane assay in nanotoxicological research—An alternative for in vivo experimentation. Nanomaterials, 10(12), 2328.
Cerbu, C., Kah, M., White, J. C., Astete, C. E., & Sabliov, C. M. (2021). Fate of biodegradable engineered nanoparticles used in veterinary medicine as delivery systems from a one health perspective. Molecules, 26(3), 523.
Chauhan, A. S. (2018). Dendrimers for drug delivery. Molecules, 23(4), 938.
Chibuk, J., Flory, A., Kruglyak, K. M., Leibman, N., Nahama, A., Dharajiya, N., Van den Boom, D., Jensen, T. J., Friedman, J. S., & Shen, M. R. (2021). Horizons in veterinary precision oncology: fundamentals of cancer genomics and applications of liquid biopsy for the detection, characterization, and management of cancer in dogs. Frontiers in Veterinary Science, 8, 664718.
Chouhan, R. S., Horvat, M., Ahmed, J., Alhokbany, N., Alshehri, S. M., & Gandhi, S. (2021). Magnetic nanoparticles—A multifunctional potential agent for diagnosis and therapy. Cancers, 13(9), 2213.
Chrishtop, V. V., Mironov, V. A., Prilepskii, A. Y., Nikonorova, V. G., & Vinogradov, V. V. (2021). Organ-specific toxicity of magnetic iron oxide-based nanoparticles. Nanotoxicology, 15(2), 167-204.
Crintea, A., Dutu, A. G., Samasca, G., Florian, I. A., Lupan, I., & Craciun, A. M. (2021). The nanosystems involved in treating lung cancer. Life, 11(7), 682.
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V. (2016). Mechanistic basis of antimicrobial actions of silver nanoparticles. Frontiers in Microbiology, 7, 1831.
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017). Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. International journal of nanomedicine, 7291-7309.
DiStasio, N., Lehoux, S., Khademhosseini, A., & Tabrizian, M. (2018). The multifaceted uses and therapeutic advantages of nanoparticles for atherosclerosis research. Materials, 11(5), 754.
Duan, X., He, C., Kron, S. J., & Lin, W. (2016). Nanoparticle formulations of cisplatin for cancer therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 8(5), 776-791.
El-Kenawy, A. E.-M., Constantin, C., Hassan, S. M., Mostafa, A. M., Neves, A. F., De Araújo, T. G., & Neagu, M. (2017). Nanomedicine in melanoma: Current trends and future perspectives. Exon Publications, 143-159.
Entzian, K., & Aigner, A. (2021). Drug delivery by ultrasound-responsive nanocarriers for cancer treatment. Pharmaceutics, 13(8), 1135.
Fawzy, M., Khairy, G. M., Hesham, A., Rabaan, A. A., El-Shamy, A. G., & Nagy, A. (2021). Nanoparticles as a novel and promising antiviral platform in veterinary medicine. Archives of virology, 166, 2673-2682.
Fu, Z., & Xiang, J. (2020). Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy. International Journal of Molecular Sciences, 21(23), 9123.
Gabizon, A. A., Barenholz, Y., & Bialer, M. (1993). Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharmaceutical research, 10, 703-708.
Gadag, S., Sinha, S., Nayak, Y., Garg, S., & Nayak, U. Y. (2020). Combination therapy and nanoparticulate systems: smart approaches for the effective treatment of breast cancer. Pharmaceutics, 12(6), 524.
Gao, Q., Zhang, J., Gao, J., Zhang, Z., Zhu, H., & Wang, D. (2021). Gold nanoparticles in cancer theranostics. Frontiers in bioengineering and biotechnology, 9, 647905.
Gerosa, C., Crisponi, G., Nurchi, V. M., Saba, L., Cappai, R., Cau, F., Faa, G., Van Eyken, P., Scartozzi, M., & Floris, G. (2020). Gold nanoparticles: a new golden era in oncology? Pharmaceuticals, 13(8), 192.
Graham, U. M., Jacobs, G., Yokel, R. A., Davis, B. H., Dozier, A. K., Birch, M. E., Tseng, M. T., Oberdörster, G., Elder, A., & DeLouise, L. (2017). From dose to response: in vivo nanoparticle processing and potential toxicity. Modelling the toxicity of nanoparticles, 71-100.
Guan, T., Shang, W., Li, H., Yang, X., Fang, C., Tian, J., & Wang, K. (2017). From detection to resection: photoacoustic tomography and surgery guidance with indocyanine green loaded gold nanorod@ liposome core–shell nanoparticles in liver cancer. Bioconjugate chemistry, 28(4), 1221-1228.
He, H., Yuan, D., Wu, Y., & Cao, Y. (2019). Pharmacokinetics and pharmacodynamics modeling and simulation systems to support the development and regulation of liposomal drugs. Pharmaceutics, 11(3), 110.
Hong, S.-S., Oh, K. T., Choi, H.-G., & Lim, S.-J. (2019). Liposomal formulations for nose-to-brain delivery: recent advances and future perspectives. Pharmaceutics, 11(10), 540.
Hua, S., De Matos, M. B., Metselaar, J. M., & Storm, G. (2018). Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Frontiers in pharmacology, 9, 790.
Ismail, T., Lee, H. K., Kim, C., Kim, Y., Lee, H., Kim, J. H., Kwon, S., Huh, T. L., Khang, D., & Kim, S. H. (2019). Comparative analysis of the developmental toxicity in Xenopus laevis and Danio rerio induced by Al2O3 nanoparticle exposure. Environmental toxicology and chemistry, 38(12), 2672-2681.
Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018). Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein journal of nanotechnology, 9(1), 1050-1074.
Jia, R., Teng, L., Gao, L., Su, T., Fu, L., Qiu, Z., & Bi, Y. (2021). Advances in multiple stimuli-responsive drug-delivery systems for cancer therapy. International journal of nanomedicine, 1525-1551.
Jia, W., Wu, Y., Xie, Y., Yu, M., & Chen, Y. Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation. Advanced Materials, 2413603.
Kischkel, B., Rossi, S. A., Santos, S. R., Nosanchuk, J. D., Travassos, L. R., & Taborda, C. P. (2020). Therapies and vaccines based on nanoparticles for the treatment of systemic fungal infections. Frontiers in Cellular and Infection Microbiology, 10, 463.
Klein, A. L., Nugent, G., Cavendish, J., Geldenhuys, W. J., Sriram, K., Porter, D., Fladeland, R., Lockman, P. R., & Sherman, J. H. (2021). Nanoparticles as a Tool in Neuro-Oncology Theranostics. Pharmaceutics, 13(7), 948.
Labens, R., Daniel, C., Hall, S., Xia, X.-R., & Schwarz, T. (2017). Effect of intra-articular administration of superparamagnetic iron oxide nanoparticles (SPIONs) for MRI assessment of the cartilage barrier in a large animal model. Plos one, 12(12), e0190216.
Lee, H., Shields, A. F., Siegel, B. A., Miller, K. D., Krop, I., Ma, C. X., LoRusso, P. M., Munster, P. N., Campbell, K., & Gaddy, D. F. (2017). 64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer. Clinical Cancer Research, 23(15), 4190-4202.
Lila, A. S. A., & Ishida, T. (2017). Liposomal delivery systems: design optimization and current applications. Biological and pharmaceutical bulletin, 40(1), 1-10.
Lin, W., Colombani‐Garay, D., Huang, L., Duan, C., & Han, G. (2020). Tailoring nanoparticles based on boron dipyrromethene for cancer imaging and therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 12(4), e1627.
Liu, X., Yang, Y., & Urban, M. W. (2017). Stimuli‐responsive polymeric nanoparticles. Macromolecular rapid communications, 38(13), 1700030.
Liu, Y., Zhang, P., Li, F., Jin, X., Li, J., Chen, W., & Li, Q. (2018). Metal-based nanoenhancers for future radiotherapy: radiosensitizing and synergistic effects on tumor cells. Theranostics, 8(7), 1824.
López-Sagaseta, J., Malito, E., Rappuoli, R., & Bottomley, M. J. (2016). Self-assembling protein nanoparticles in the design of vaccines. Computational and structural biotechnology journal, 14, 58-68.
Lorkowski, M. E., Atukorale, P. U., Ghaghada, K. B., & Karathanasis, E. (2021). Stimuli‐Responsive iron oxide nanotheranostics: A versatile and powerful approach for cancer therapy. Advanced healthcare materials, 10(5), 2001044.
Luo, D., Wang, X., Burda, C., & Basilion, J. P. (2021). Recent development of gold nanoparticles as contrast agents for cancer diagnosis. Cancers, 13(8), 1825.
Madru, R., Kjellman, P., Olsson, F., Wingårdh, K., Ingvar, C., Ståhlberg, F., Olsrud, J., Lätt, J., Fredriksson, S., & Knutsson, L. (2012). 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes. Journal of Nuclear Medicine, 53(3), 459-463.
Mathur, P., Jha, S., Ramteke, S., & Jain, N. (2018). Pharmaceutical aspects of silver nanoparticles. Artificial cells, nanomedicine, and biotechnology, 46(sup1), 115-126.
Mavridi-Printezi, A., Guernelli, M., Menichetti, A., & Montalti, M. (2020). Bio-applications of multifunctional melanin nanoparticles: from nanomedicine to nanocosmetics. Nanomaterials, 10(11), 2276.
Mochel, J. P., Ekker, S. C., Johannes, C. M., Jergens, A. E., Allenspach, K., Bourgois-Mochel, A., Knouse, M., Benzekry, S., Wierson, W., & LeBlanc, A. K. (2019). CAR T cell immunotherapy in human and veterinary oncology: changing the odds against hematological malignancies. The AAPS Journal, 21, 1-12.
Mohammadpour, R., Dobrovolskaia, M. A., Cheney, D. L., Greish, K. F., & Ghandehari, H. (2019). Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications. Advanced drug delivery reviews, 144, 112-132.
Mohapatra, A., Uthaman, S., & Park, I.-K. (2021). External and internal stimuli-responsive metallic nanotherapeutics for enhanced anticancer therapy. Frontiers in molecular biosciences, 7, 597634.
Moore, C., Chen, F., Wang, J., & Jokerst, J. V. (2019). Listening for the therapeutic window: advances in drug delivery utilizing photoacoustic imaging. Advanced drug delivery reviews, 144, 78-89.
Mourdikoudis, S., Pallares, R. M., & Thanh, N. T. (2018). Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale, 10(27), 12871-12934.
Mulens-Arias, V., Rojas, J. M., & Barber, D. F. (2020). The intrinsic biological identities of iron oxide nanoparticles and their coatings: unexplored territory for combinatorial therapies. Nanomaterials, 10(5), 837.
Navya, P., Kaphle, A., Srinivas, S., Bhargava, S. K., Rotello, V. M., & Daima, H. K. (2019). Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano convergence, 6(1), 23.
Naz, S., Gul, A., & Zia, M. (2020). Toxicity of copper oxide nanoparticles: a review study. IET nanobiotechnology, 14(1), 1-13.
Ni, K., Lan, G., & Lin, W. (2020). Nanoscale metal–organic frameworks generate reactive oxygen species for cancer therapy. ACS central science, 6(6), 861-868.
Nicolas, J. (2016). Drug-initiated synthesis of polymer prodrugs: combining simplicity and efficacy in drug delivery. Chemistry of Materials, 28(6), 1591-1606.
Palmerston Mendes, L., Pan, J., & Torchilin, V. P. (2017). Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules, 22(9), 1401.
Patel, S., & Patel, R. (2023). Importance of Nanoparticles in Cancer Therapy and Drug Delivery: A Detailed Theory and Gaps.
Patlewicz, G., & Fitzpatrick, J. M. (2016). Current and future perspectives on the development, evaluation, and application of in silico approaches for predicting toxicity. Chemical research in toxicology, 29(4), 438-451.
Poilil Surendran, S., Moon, M. J., Park, R., & Jeong, Y. Y. (2018). Bioactive nanoparticles for cancer immunotherapy. International Journal of Molecular Sciences, 19(12), 3877.
Qin, X., & Li, Y. (2020). Strategies To Design and Synthesize Polymer‐Based Stimuli‐Responsive Drug‐Delivery Nanosystems. ChemBioChem, 21(9), 1236-1253.
Raies, A. B., & Bajic, V. B. (2016). In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdisciplinary Reviews: Computational Molecular Science, 6(2), 147-172.
Ramos, A. P., Cruz, M. A., Tovani, C. B., & Ciancaglini, P. (2017). Biomedical applications of nanotechnology. Biophysical reviews, 9(2), 79-89.
Riaz, M. K., Riaz, M. A., Zhang, X., Lin, C., Wong, K. H., Chen, X., Zhang, G., Lu, A., & Yang, Z. (2018). Surface functionalization and targeting strategies of liposomes in solid tumor therapy: A review. International Journal of Molecular Sciences, 19(1), 195.
Riley, R. S., & Day, E. S. (2017). Gold nanoparticle‐mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 9(4), e1449.
Sherje, A. P., Jadhav, M., Dravyakar, B. R., & Kadam, D. (2018). Dendrimers: A versatile nanocarrier for drug delivery and targeting. International journal of pharmaceutics, 548(1), 707-720.
Signorell, R. D., Luciani, P., Brambilla, D., & Leroux, J.-C. (2018). Pharmacokinetics of lipid-drug conjugates loaded into liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 128, 188-199.
Skakic, I., Francis, J. E., & Smooker, P. M. (2022). Design and Synthesis of Protein-Based Nanocapsule Vaccines. Vaccine Design: Methods and Protocols, Volume 3. Resources for Vaccine Development, 339-354.
Skóra, B., Piechowiak, T., & Szychowski, K. A. (2024). Engagement of specific intracellular pathways in the inflammation-based reprotoxicity effect of small-size silver nanoparticles on spermatogonia and spermatocytes in vitro cell models. Chemosphere, 363, 142897.
Su, S., & Kang, P. M. (2020). Systemic review of biodegradable nanomaterials in nanomedicine. Nanomaterials, 10(4), 656.
Upputuri, P. K., & Pramanik, M. (2020). Recent advances in photoacoustic contrast agents for in vivo imaging. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 12(4), e1618.
Vallabani, N. S., & Singh, S. (2018). Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics. 3 Biotech, 8(6), 279.
Varma, L. T., Singh, N., Gorain, B., Choudhury, H., Tambuwala, M. M., Kesharwani, P., & Shukla, R. (2020). Recent advances in self-assembled nanoparticles for drug delivery. Current Drug Delivery, 17(4), 279-291.
Vines, J. B., Yoon, J.-H., Ryu, N.-E., Lim, D.-J., & Park, H. (2019). Gold nanoparticles for photothermal cancer therapy. Frontiers in chemistry, 7, 167.
Wang, H., Huang, Q., Chang, H., Xiao, J., & Cheng, Y. (2016). Stimuli-responsive dendrimers in drug delivery. Biomaterials science, 4(3), 375-390.
Wang, J., Li, B., Qiu, L., Qiao, X., & Yang, H. (2022). Dendrimer-based drug delivery systems: History, challenges, and latest developments. Journal of Biological Engineering, 16(1), 18.
Wang, L., Gong, C., Yuan, X., & Wei, G. (2019). Controlling the self-assembly of biomolecules into functional nanomaterials through internal interactions and external stimulations: A review. Nanomaterials, 9(2), 285.
Wustefeld‐Janssens, B., Smith, L., & Wilson‐Robles, H. (2021). Neoadjuvant chemotherapy and radiation therapy in veterinary cancer treatment: a review. Journal of Small Animal Practice, 62(4), 237-243.
Yan, Y., Liu, Y., Li, T., Liang, Q., Thakur, A., Zhang, K., Liu, W., Xu, Z., & Xu, Y. (2023). Functional roles of magnetic nanoparticles for the identification of metastatic lymph nodes in cancer patients. Journal of Nanobiotechnology, 21(1), 337.
Yang, W., Wang, L., Mettenbrink, E. M., DeAngelis, P. L., & Wilhelm, S. (2021). Nanoparticle toxicology. Annual Review of Pharmacology and Toxicology, 61(1), 269-289.
Youssef, F. S., El-Banna, H. A., Elzorba, H. Y., & Galal, A. M. (2019). Application of some nanoparticles in the field of veterinary medicine. International journal of veterinary science and medicine, 7(1), 78-93.
Zabielska-Koczywąs, K., & Lechowski, R. (2017). The use of liposomes and nanoparticles as drug delivery systems to improve cancer treatment in dogs and cats. Molecules, 22(12), 2167.
Zhang, X.-F., Liu, Z.-G., Shen, W., & Gurunathan, S. (2016). Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. International Journal of Molecular Sciences, 17(9), 1534.
Zhang, Y., Yang, L., Yang, C., & Liu, J. (2020). Recent advances of smart acid‐responsive gold nanoparticles in tumor therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 12(4), e1619.
Zhu, L., Zhou, Z., Mao, H., & Yang, L. (2017). Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy. Nanomedicine, 12(1), 73-87.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
